Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Fassil Mesfin

Neurological Surgery Columbia, MO Medical Doctor

NPI 1992968218 CMS profile 317336

1100 Virginia Ave, Ste 7A, Columbia, MO 65212

Open in the dashboard

General payments

$14,676

79 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$200,000

4 holdings reported · through program year 2025

Research they led as principal investigator

$1,500 paid to institutions, not to them · program years 2020–2022

Through program year 2025, Fassil Mesfin of Columbia, MO is reported in the CMS Open Payments database as having received $14,676 across 79 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,500 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $200,000 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 75th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $371 6
2024 General $274 6
2023 General $492 7
2022 General $3,746 14
2021 General $1,788 8
2020 General $1,642 13
2019 General $6,363 25
2025 Ownership $50,000 1
2024 Ownership $50,000 1
2023 Ownership $50,000 1
2022 Ownership $50,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Fassil Mesfin
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Fassil Mesfin were reported at $371. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Fassil Mesfin Neurological Surgery median Middle half National median
2019 $6,363 $582 $138–$3,006 $163
2020 $1,642 $294 $76–$2,174 $114
2021 $1,788 $387 $105–$2,432 $132
2022 $3,746 $542 $139–$2,989 $149
2023 $492 $534 $145–$2,697 $160
2024 $274 $574 $155–$3,046 $164
2025 $371 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Spinefrontier, Inc. $4,628 12 payments
  2. Globus Medical, Inc. $4,385 13 payments
  3. Stryker Corporation $1,763 15 payments
  4. Medical Device Business Services, Inc. $1,357 6 payments
  5. Medtronic, Inc. $774 15 payments
  6. GS Solutions, Inc. $334 2 payments
  7. ulrich medical USA, Inc. $325 3 payments
  8. Synthes GmbH $250 1 payment
  9. DePuy Synthes Sales Inc. $199 5 payments
  10. NuVasive, Inc. $165 1 payment
  11. Other $496 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $11,318 29 payments
  2. Food and Beverage $3,030 48 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $250 1 payment
  4. Entertainment $79 1 payment
Products named General payments · program years 2019–2025
  1. PedFuse Reset $4,604 11 payments
  2. INSET $4,604 11 payments
  3. MISQUITO $4,604 11 payments
  4. Excelsius Robotics System $2,268 8 payments
  5. EXPEDIUM $1,357 6 payments
  6. EXCELSIUS GPS $1,091 2 payments
  7. Spine $792 1 payment
  8. GENERAL K2M PRODUCT DISCUSSION $770 7 payments
  9. ADVANCED PRODUCT DEVELOPMENT $591 3 payments
  10. OSTEOCOOL RF ABLATION SYSTEM $210 6 payments
  11. Other $2,242 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 57 billing codes

Paid by Medicare

$90,822

Medicare's payments for the services billed

Medicare patients

129

Average age 75

Services billed

258

65 women, 64 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Depression 47%
Diabetes 43%
Ischemic heart disease 40%
Chronic kidney disease 36%
Atrial fibrillation 28%
Alzheimer's or dementia 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

79 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record